BridgeMD
New treatment option for Caesarean Section
Official title The Effect of Two Methods Applied to Mothers on Insufficient Milk Perception, Breastfeeding Motivation, Fatigue, Anxiety
ClinicalTrials.gov ID: NCT06687447
What this study is testing
- What it's testing
- Although the World Health Organization predicts the caesarean section rate to be 10-15%, the caesarean section rate in Turkey is 52%, more than three times the international standard. It is very important to eliminate the physical and psychosocial problems experienced by women during this period, to encourage breastfeeding, and at the same time to protect and improve maternal health.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older, women only. Healthy volunteers may be eligible.
You may be able to join if
- Mothers who gave birth at the age of 18 and over
- The one who is married
- At least primary school graduate,
- Primiparous mothers who gave birth by cesarean section,
- Having a single, healthy newborn at full term,
You likely can't join if
- Those who gave birth by cesarean section before the 37th week of pregnancy,
- Women who gave birth by cesarean section with combined anesthesia,
- Discharged before 36 hours after birth,
- Having chronic diseases such as heart disease, diabetes, hypertension,
- Those with infectious diseases, infections, open wounds, masses, fractures, dislocations, deformities, varicose veins, burns, eczema, hematomas...
- Experiencing any postpartum complications,
See the full eligibility criteria
- Mothers who gave birth at the age of 18 and over
- The one who is married
- At least primary school graduate,
- Primiparous mothers who gave birth by cesarean section,
- Having a single, healthy newborn at full term,
- Those who did not experience any problems during pregnancy and the early postpartum period,
- The tissue integrity in the area to be applied is complete and healthy,
- Breastfeeding her baby after birth,
- The baby is healthy, has no problems with the sucking reflex and does not have any congenital anomalies,
- Women who agree to participate in the research will be included in the study.
- Those who gave birth by cesarean section before the 37th week of pregnancy,
- Women who gave birth by cesarean section with combined anesthesia,
- Discharged before 36 hours after birth,
- Having chronic diseases such as heart disease, diabetes, hypertension,
- Those with infectious diseases, infections, open wounds, masses, fractures, dislocations, deformities, varicose veins, burns, eczema, hematomas, thrombophlebitis, deep vein thrombosis on the foot skin,
- Experiencing any postpartum complications,
- Their baby is not with their mother for any reason,
- Those who have received a psychiatric diagnosis such as anxiety and depression,
- Women who want to leave the research at any stage of the research
The study team makes the final eligibility decision.
Where it's taking place
- Giresun, Turkey (Türkiye)
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling female, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Giresun, Turkey (Türkiye). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.